Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.6171
+0.0541 (9.61%)
At close: Sep 26, 2025, 4:00 PM EDT
0.6349
+0.0178 (2.88%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Plus Therapeutics Stock Forecast
PSTV's stock price has decreased by -59.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Plus Therapeutics stock ranges from a low of $3.00 to a high of $20.5. The average analyst price target of $7.88 forecasts a 1,176.94% increase in the stock price over the next year.
Price Target: $7.88 (+1,176.94%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Plus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +710.24% | Sep 25, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +710.24% | Sep 22, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +710.24% | Sep 18, 2025 |
| D. Boral Capital | D. Boral Capital | Hold → Strong Buy Upgrades $5 | Hold → Strong Buy | Upgrades | $5 | +710.24% | Sep 3, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +386.14% | Aug 18, 2025 |
Financial Forecast
Revenue This Year
7.46M
from 5.82M
Increased by 28.09%
Revenue Next Year
7.27M
from 7.46M
Decreased by -2.61%
EPS This Year
-0.47
from -2.34
EPS Next Year
-0.20
from -0.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.9M | 12.7M | |||
| Avg | 7.5M | 7.3M | |||
| Low | 5.1M | 3.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 69.4% | 70.5% | |||
| Avg | 28.1% | -2.6% | |||
| Low | -12.0% | -47.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.11 | -0.05 | |||
| Avg | -0.47 | -0.20 | |||
| Low | -0.80 | -0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.